Vokes EE - Search Results

1

Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.

Cohen EE, Haraf DJ, Kunnavakkam R, Stenson KM, Blair EA, Brockstein B, Lester EP, Salama JK, Dekker A, Williams R, Witt ME, Grushko TA, Dignam JJ, Lingen MW, Olopade OI, Vokes EE. Cohen EE, et al. Among authors: vokes ee. J Clin Oncol. 2010 Jul 10;28(20):3336-43. doi: 10.1200/JCO.2009.27.0397. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498391 Free PMC article. Clinical Trial.

2

Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.

Brachman DG, Graves D, Vokes E, Beckett M, Haraf D, Montag A, Dunphy E, Mick R, Yandell D, Weichselbaum RR. Brachman DG, et al. Cancer Res. 1992 Sep 1;52(17):4832-6. Cancer Res. 1992. PMID: 1324797

3

Vascular events in patients receiving high-dose infusional 5-fluorouracil-based chemotherapy: the University of Chicago experience.

Gradishar W, Vokes E, Schilsky R, Weichselbaum R, Panje W. Gradishar W, et al. Med Pediatr Oncol. 1991;19(1):8-15. doi: 10.1002/mpo.2950190103. Med Pediatr Oncol. 1991. PMID: 1990260

4

Surgical management of the head and neck cancer patient following concomitant multimodality therapy.

Panje WR, Namon AJ, Vokes E, Haraf DJ, Weichselbaum RR. Panje WR, et al. Laryngoscope. 1995 Jan;105(1):97-101. doi: 10.1288/00005537-199501000-00021. Laryngoscope. 1995. PMID: 7837923

5

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer.

Taylor SG 4th, Murthy AK, Vannetzel JM, Colin P, Dray M, Caldarelli DD, Shott S, Vokes E, Showel JL, Hutchinson JC, et al. Taylor SG 4th, et al. J Clin Oncol. 1994 Feb;12(2):385-95. doi: 10.1200/JCO.1994.12.2.385. J Clin Oncol. 1994. PMID: 8113846 Clinical Trial.

6

p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.

Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR. Brachman DG, et al. Cancer Res. 1993 Aug 15;53(16):3667-9. Cancer Res. 1993. PMID: 8339273

7

The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity.

List MA, D'Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E. List MA, et al. Cancer. 1996 Jun 1;77(11):2294-301. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S. Cancer. 1996. PMID: 8635098

8

Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer.

List MA, Mumby P, Haraf D, Siston A, Mick R, MacCracken E, Vokes E. List MA, et al. Qual Life Res. 1997 Apr;6(3):274-84. doi: 10.1023/a:1026419023481. Qual Life Res. 1997. PMID: 9226985

9

Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group.

Schrijvers D, Johnson J, Jiminez U, Gore M, Kosmidis P, Szpirglas H, Robbins K, Oliveira J, Lewensohn R, Schüller J, Riviere A, Arvay C, Langecker P, Jacob H, Cvitkovic E, Vokes E. Schrijvers D, et al. J Clin Oncol. 1998 Mar;16(3):1054-9. doi: 10.1200/JCO.1998.16.3.1054. J Clin Oncol. 1998. PMID: 9508190 Clinical Trial.

10

A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Saxman S, Mann B, Canfield V, Loehrer P, Vokes E. Saxman S, et al. Am J Clin Oncol. 1998 Aug;21(4):398-400. doi: 10.1097/00000421-199808000-00016. Am J Clin Oncol. 1998. PMID: 9708641 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

559 results

Search Page